Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Rheumatic Disease ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Mortality and cardiovascular morbidity among patients diagnosed with Takayasu’s arteritis: a Danish nationwide cohort study.Clin Exp Rheumatol. 2020; 38 Suppl 124: 91-94
- Overall and cause-specific mortality in giant cell arteritis : a meta-analysis.Z Rheumatol. 2018; 77: 946-951
- Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.J Rheumatol. 2002; 29: 737-742
- Pathogenesis of giant cell arteritis and takayasu arteritis-similarities and differences.Curr Rheumatol Rep. 2020; 22: 68
- Epidemiology of Takayasu arteritis.Presse Médicale. 2017; 46: e197-e203
- Medium- and large-vessel vasculitis.N Engl J Med. 2003; 349: 160-169
- Takayasu arteritis.Ann Intern Med. 1994; 120: 919-929
- Medium- and large-vessel vasculitis.Circulation. 2021; 143: 267-282
- Overall survival and mortality risk factors in Takayasu’s arteritis: a multicenter study of 318 patients.J Autoimmun. 2019; 96: 35-39
- Takayasu’s arteritis. Clinical study of 107 cases.Am Heart J. 1977; 93: 94-103
- Long-term outcome for 120 Japanese patients with Takayasu’s disease. Clinical and statistical analyses of related prognostic factors.Circulation. 1994; 90: 1855-1860
- Ischemic complications in Takayasu’s arteritis: a meta-analysis.Semin Arthritis Rheum. 2018; 47: 900-906
- Assessment of the frequency of cardiovascular risk factors in patients with Takayasu’s arteritis.Rheumatol Oxf Engl. 2017; 56: 1939-1944
- Anaemia and low body mass index are associated with increased cardiovascular disease in patients with Takayasu arteritis.Clin Exp Rheumatol. 2016; 34: S16-S20
- Disease-specific factors associated with cardiovascular events in patients with Takayasu arteritis.Arthritis Res Ther. 2020; 22: 180
- Coronary involvement in Takayasu’s arteritis.Autoimmun Rev. 2007; 6: 566-571
- Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis.J Thorac Cardiovasc Surg. 2003; 125: 570-577
- Impact of coronary involvement on long-term outcomes in patients with Takayasu’s arteritis.Clin Exp Rheumatol. 2020; 38: 1118-1126
- Takayasu arteritis with coronary artery involvement: differences between pediatric and adult patients.Can J Cardiol. 2020; 36: 535-542
- Clinical course and prognostic factors of childhood Takayasu’s arteritis: over 15-year comprehensive analysis of 101 patients.Arthritis Res Ther. 2019; 21: 31
- Pathological studies on Takayasu arteritis.Heart Vessels Suppl. 1992; 7: 11-17
- Coronary artery lesions in Takayasu arteritis: pathological considerations.Heart Vessels Suppl. 1992; 7: 26-31
- Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage.J Rheumatol. 2001; 28: 2752-2753
- Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.Ann Intern Med. 2014; 160: 73-80
- Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study.Rheumatol Oxf Engl. 2016; 55: 33-40
- Coronary artery disease in giant cell arteritis: a systematic review and meta-analysis.Semin Arthritis Rheum. 2015; 44: 586-591
- Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.Rheumatol Oxf Engl. 2017; 56: 753-762
- Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation.Semin Arthritis Rheum. 1995; 24: 422-431
- Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement.Arch Neurol. 1972; 27: 378-391
- Fatal myocardial infarction resulting from coronary arteritis in a patient with polymyalgia rheumatica and biopsy-proved temporal arteritis. A case report and review of the literature.Arch Intern Med. 1994; 154: 1158-1160
- A rare case of coronary artery thrombosis in a patient with recently diagnosed giant cell arteritis: is anticardiolipin antibody involved?.Cureus. 2020; 12: e8077
- Vascular calcification in patients with large-vessel vasculitis compared to patients with hyperlipidemia.Semin Arthritis Rheum. 2019; 48: 1068-1073
- Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis.Circ J Off J Jpn Circ Soc. 2010; 74: 1236-1241
- Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center.Int J Cardiol. 2012; 159: 14-20
- Inpatient prevalence, burden and comorbidity of Takayasu’s arteritis: Nationwide inpatient sample 2013-2014.Semin Arthritis Rheum. 2019; 49: 136-139
- Stroke and transient ischemic attack in takayasu’s arteritis: a systematic review and meta-analysis.J Stroke Cerebrovasc Dis. 2016; 25: 781-791
- Cerebrovascular manifestations of Takayasu arteritis in Europe.Rheumatol Oxf Engl. 2005; 44: 1012-1015
- Intracranial and extracranial neurovascular manifestations of takayasu arteritis.AJNR Am J Neuroradiol. 2017; 38: 766-772
- Atherosclerosis in takayasu arteritis.Ann Rheum Dis. 2006; 65: 1202-1207
- [Takayasu’s arteritis and atherosclerosis].J Med Vasc. 2019; 44: 311-317
- Cerebrovascular accident in patients with giant cell arteritis: A systematic review and meta-analysis of cohort studies.Semin Arthritis Rheum. 2016; 46: 361-366
- Ischemic stroke in giant-cell arteritis: French retrospective study.J Autoimmun. 2019; 99: 48-51
- 3T MRI reveals extra- and intracranial involvement in giant cell arteritis.AJNR Am J Neuroradiol. 2015; 36: 91-97
- Involvement of the intracranial circulation in giant cell arteritis.Can J Ophthalmol J Can Ophtalmol. 2020; 55https://doi.org/10.1016/j.jcjo.2020.04.002
- Stroke associated with giant cell arteritis: a population-based study.J Neurol Neurosurg Psychiatr. 2015; 86: 216-221
- Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis.Medicine (Baltimore). 2009; 88: 227-235
- Giant cell arteritis-related stroke: a retrospective multicenter case-control study.J Rheumatol. 2017; 44: 297-303
- Atherosclerosis in patients with biopsy-proven giant cell arteritis.Arthritis Rheum. 2007; 57: 1481-1486
- Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years.Arthritis Rheum. 2003; 48: 3522-3531
- Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years.Arthritis Rheum. 2003; 48: 3532-3537
- Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation).Ann Rheum Dis. 2014; 73: 1826-1832
- Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study.Medicine (Baltimore). 2004; 83: 335-341
- Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.Arthritis Rheum. 2006; 55: 131-137
- Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography.Ann Rheum Dis. 2012; 71: 1170-1176
- Incidence and predictors of thoracic aortic damage in biopsy-proven giant cell arteritis.Scand J Rheumatol. 2021; 50: 239-242
- The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.Ann Rheum Dis. 2015; 74: 129-135
- Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT.Semin Arthritis Rheum. 2019; 48: 1074-1082
- Investigations in systemic vasculitis - The role of imaging.Best Pract Res Clin Rheumatol. 2018; 32: 63-82
- Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis.Rheumatol Oxf Engl. 2008; 47: 1179-1184
- The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.Ann Rheum Dis. 2016; 75: 148-154
- Temporal trends of venous thromboembolism risk before and after diagnosis of giant cell arteritis.Arthritis Rheumatol Hoboken NJ. 2017; 69: 176-184
- Takayasu’s disease in twin sisters. Possible genetic factors.Circulation. 1978; 58: 173-177
- HLA and clinical manifestations in Takayasu disease.Jpn Circ J. 1982; 46: 184-189
- Left ventricular dysfunction and HLA Bw52 antigen in Takayasu arteritis.Heart Vessels Suppl. 1992; 7: 116-119
- Two susceptibility loci to takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a japanese population.Am J Hum Genet. 2013; 93: 289-297
- A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.Am J Hum Genet. 2015; 96: 565-580
- A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.Am J Hum Genet. 2017; 100: 64-74
- Genetic evidence for PLASMINOGEN as a shared genetic risk factor of coronary artery disease and periodontitis.Circ Cardiovasc Genet. 2015; 8: 159-167
- Which patients with giant cell arteritis will develop cardiovascular or cerebrovascular disease? A clinical practice research datalink study.J Rheumatol. 2016; 43: 1085-1092
- Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis.Am J Cardiol. 2014; 113: 881-887
- High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels.J Rheumatol. 2013; 40: 1897-1904
- Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study.Scand J Rheumatol. 2019; 48: 213-217
- Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study.Arthritis Care Res. 2015; 67: 396-402
- Early development of new cardiovascular risk factors in the systemic vasculitides.Clin Exp Rheumatol. 2020; 38 Suppl 124: 126-134
- Risk factors for symptomatic vascular events in giant cell arteritis: a study of 254 patients with large-vessel imaging at diagnosis.Ther Adv Musculoskelet Dis. 2021; 13 (1759720X211006967)
- Numano type V Takayasu arteritis patients are more prone to have coronary artery involvement.Clin Rheumatol. 2020; 39: 3439-3447
- Brachial-ankle pulse wave velocity is increased and associated with disease activity in patients with takayasu arteritis.J Atheroscler Thromb. 2020; 27: 172-182
- Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis.J Rheumatol. 2006; 33: 74-78
- Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu Arteritis.Sci Rep. 2021; 11: 14404
- Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages.Arthritis Rheum. 2008; 58: 3675-3683
- Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging.Redox Biol. 2017; 13: 588-593
- Efficacy and safety of biological agents in the treatment of patients with Takayasu arteritis: a systematic review and meta-analysis.Eur Rev Med Pharmacol Sci. 2021; 25: 250-262
- Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.Rheumatol Oxf Engl. 2020; 59: 2427-2434
- Regressed coronary ostial stenosis in a young female with Takayasu arteritis: a case report.BMC Cardiovasc Disord. 2019; 19: 79
- Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.Clin Rheumatol. 2020; 39: 2369-2378
- Anti-TNF Therapy Against Congestive Heart Failure Investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.Circulation. 2003; 107: 3133-3140
- Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.Arthritis Rheum. 2006; 54: 3310-3318
- Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis.Semin Arthritis Rheum. 2016; 46: 246-252
- Risk associated with cumulative oral glucocorticoid use in patients with giant cell arteritis in real-world databases from the USA and UK.Rheumatol Ther. 2018; 5: 327-340
- Trial of tocilizumab in giant-cell arteritis.N Engl J Med. 2017; 377: 317-328
- Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations.Arthritis Res Ther. 2021; 23: 8
- Adverse events in giant cell arteritis and rheumatoid arthritis patient populations: analyses of tocilizumab clinical trials and claims data.Rheumatol Ther. 2019; 6: 77-88
- Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.Arthritis Rheum. 2004; 50: 1332-1337
- Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.Arthritis Rheum. 2006; 54: 3306-3309
- Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis.Clin Exp Rheumatol. 2008; 26: S57-S62
- Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis.Autoimmun Rev. 2014; 13: 788-794
- Management of giant cell arteritis: recommendations of the french study group for large vessel vasculitis (GEFA).Rev Med Interne. 2016; 37: 154-165
- British society for rheumatology guideline on diagnosis and treatment of giant cell arteritis.Rheumatol Oxf Engl. 2020; 59: e1-e23
- 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.Ann Rheum Dis. 2020; 79: 19-30
- Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.Circulation. 1999; 100: 230-235
- Effect of atorvastatin and pravastatin on serum C-reactive protein.Am Heart J. 2003; 145: e8
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.N Engl J Med. 2008; 359: 2195-2207
- Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?.Curr Atheroscler Rep. 2011; 13: 31-42
- Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?.Am J Cardiol. 2006; 97: 33A-41A
- Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study.J Rheumatol. 2015; 42: 316-322
- Giant cell arteritis and polymyalgia rheumatica after reexposure to a statin: a case report.Ann Intern Med. 2014; 161: 614-615
- Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study.J Rheumatol. 2016; 43: 2162-2170
- Statin therapy does not seem to benefit giant cell arteritis.Semin Arthritis Rheum. 2007; 36: 322-327
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.Can J Cardiol. 2021; (S0828-282X(21)00165-3)https://doi.org/10.1016/j.cjca.2021.03.016
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
